What Does Rhizome Partners Think About CLMT’s Recent Performance?
Insider Monkey published the Q2 2019 Commentary of Rhizome Partners, you may read it here. In the said letter, Rhizome’s Managing Partner Bill Chen......(read more)
Stock Analysis
US Equities: Resilient Force or Case Study in Denial?
As readers of this blog know, I don’t write much about whether stocks collectively are over or under priced, other than my usual start of the year......(read more)
Why is Rhizome Partners Bullish About LAACZ?
Insider Monkey recently published Rhizome Partners’ Q2 2019 Commentary. In the said report, Rhizome’s Bill Chen highlighted a few stocks,......(read more)
Does Rhizome Partners Still Believe in BERY?
Insider Monkey has recently published a copy of Rhizome Partners’ Q2 2019 Commentary. In the said letter, Rhizome Partners highlighted a few stocks......(read more)
Was Rhizome Partners Right About Griffin Industrial Realty, Inc. (GRIF)?
Insider Monkey has published a copy of Rhizome Partners’ 2019 Q2 investor letter. One of the stocks in the letter Rhizome talked about was Griffin......(read more)
Rhizome Partners Took A Victory Lap on The Howard Hughes Corporation (HHC)
Rhizome Partners felt vindicated and took a victory lap on its The Howard Hughes Corporation (NYSE:HHC) investment. You can download a copy of Rhizome......(read more)
Insights on VC Pricing: Lessons from Uber Technologies Inc (UBER), WeWorks and Peloton Interactive, Inc. (PTON)!
As a confession, I started this post intending to write about Peloton Interactive, Inc. (NASDAQ: PTON), the next big new offering hitting markets, but......(read more)
Is Arrowhead Pharmaceuticals Inc (ARWR)’s Recently Published U.S. Patent Application A Blockbuster?
– U.S. Patent and Trademark Office publishes Arrowhead’s latest patent application on αvβ6 integrin ligands. – αvβ6 integrin ligands......(read more)
PAR Technology Corporation’s Path to $80
Two years ago, we wrote a note on PAR Technology Corporation (PAR) titled PAR: A Framework for $30. The stock got within a whisker of $30 and now subsequently......(read more)
Meatless Future or Vegan Delusions? The Beyond Meat Inc (BYND) Valuation
In a big year for initial public offerings (IPOs), with Uber, Lyft, Pinterest and Zoom, to name just a few, already having gone public and more companies......(read more)
Are Gambling Stocks a Sound Investment?
There are many gambling companies big and small that prefer to keep their matters private. There are many of them, like the owners of Spin Casino, that......(read more)
Tesla Inc (TSLA)’s Travails: Curfew for a Corporate Teenager?
It should come as no surprise to anyone that Tesla Inc (NASDAQ: TSLA) is back in the news, though it seems to be for all of the wrong reasons. From Musk......(read more)
Can Boeing Overcome the Scandal Following the 737 Max Crashes?
The Boeing Company (NYSE:BA) shares are having one of their worst runs in years following the tragic crash of Ethiopian Airlines flight 302 on March 10......(read more)
The Perils of Investing Idol Worship: The Kraft Heinz Co (KHC) Lessons!
On February 22, Kraft Heinz Co (NASDAQ: KHC) shocked investors with a trifecta of bad news in its earnings report: sub-par operating results, a mention......(read more)
Think Nice Things or Suffer a Bad $TRIP
In November 2016 I went for a job with one of the top hedge funds in Australia. I was excited. I do not have the traditional analyst background and was......(read more)
Investing Whiplash: Looking for Closure with Apple Inc. (AAPL) and Amazon.com, Inc. (AMZN)
In September, I took a look, in a series of posts, at two companies that had crested the trillion dollar market cap mark, Apple Inc. (NASDAQ:AAPL) and......(read more)
The General Electric Company (GE) End Game: Bataan Death March or Turnaround Play?
It seems like ancient history, but it was just 2001, when General Electric Company (NYSE:GE) was the most valuable company in the world, commanding a......(read more)
Jim Roumell Is Bullish On These Value Stocks: Should You Go Short Or Long?
Value stocks have been underperforming growth stocks and value investors have been hurting. According to Ken French’s calculations growth stocks......(read more)
Brighthouse Financial (BHF): A Value Trap or An Overlooked Cheap Stock?
If you are building a portfolio, then you should consider adding insurance stocks, especially if you are looking for long-term returns. Of course, insurance......(read more)
The Case Against The New York Times Co (NYT)
New York Times Co (NYSE:NYT) has enjoyed a strong bull run over the past 20 months, more than doubling in value since the beginning of October 2016, just......(read more)
Why Spotify’s Free App Upgrade Is Such A Big Win For Investors
Spotify Technology (NYSE:SPOT) has been a hot topic as of late, and for good reason. The company went public early this month, making waves in the market......(read more)
Were Fossil Group Inc (FOSL)’s 63% Q1 Gains Just the Tip of the Iceberg?
Fossil Group Inc (NASDAQ:FOSL) was one of the top performing stocks on the Nasdaq in the first quarter, jumping by 63.5%. Much of that love from the market......(read more)
How High Can Bank of America Stock Go?
Financial stocks are on the cusp of a momentous year ahead. Barring the February 2018 market correction, banking and financial stocks are on the way up......(read more)
Phyto Partners: A Venture Capital Fund Worth Following In The Marijuana Industry
Insider Monkey is in the business of identifying and following smart insiders, hedge fund managers and prominent investors. Our flagship investment strategy......(read more)
Netflix, Inc. (NFLX): Key Metrics Are Deteriorating Says Billionaire Einhorn
Netflix, Inc. (NASDAQ:NFLX) remains a major target of billionaire hedge fund manager David Einhorn of Greenlight Capital, who’s been launching verbal......(read more)
Discover Financial Services (DFS): The Rodney Dangerfield of the Credit Industry
Discover Financial Services (NYSE:DFS) doesn’t get no respect. That’s the message from Burr Capital LLC’s Rahul Ray, who discussed the......(read more)
Tesla Inc (TSLA) Presentation: Full Transcript of Chamath Palihapitiya’s Scintillating Sohn Pitch
We published an article this morning providing a detailed breakdown of the Sohn Investment Conference presentation made by Social Capital CEO Chamath......(read more)
Exclusive Breakdown of Tesla Inc (TSLA)’s 2022 Convertible Notes And Why You Should Buy Them
Social Capital CEO Chamath Palihapitiya was one of the show-stoppers at the recent Sohn Investment Conference in New York, pitching a Tesla Inc (NASDAQ......(read more)
International Game Technology Ordinary Shares (IGT): Why Double Down Interactive Sale Was a Coup
International Game Technology Ordinary Shares (NYSE:IGT) scored a very favorable deal with the sale of its Double Down Interactive unit according to commentary......(read more)
TrueCar Inc (TRUE): Will “Poor Earnings Quality” Crash This Stock?
William Martin of Raging Capital Management believes TrueCar Inc (NASDAQ:TRUE) investors should pay attention to objects in their investment’s rear......(read more)
Lions Gate Entertainment Corp. (USA) (LGF): Why Passive Investing Could Be To Blame For Lagging Stock
Lions Gate Entertainment Corp. (USA) (NYSE:LGF) investors can probably point at least some of the blame for Lions Gate’s lackadaisical stock performance......(read more)
Honeywell International Inc. (HON): Why Dan Loeb’s $20 Billion Spinoff Proposal May Be Far-Fetched
Billionaire Dan Loeb, the head of $15 billion hedge fund Third Point, has his eyes set on a $20 billion prize. The money manager’s first-quarter......(read more)
International Business Machines Corp. (IBM): Warren Buffett’s Worst Investment?
Warren Buffett of Berkshire Hathaway has been an investing machine for five decades, delivering stunning returns during that time. A mere $1,000 invested......(read more)
Tesla Inc (TSLA): Billionaire David Einhorn’s Unflattering Image of Tesla Investors
David Einhorn, the billionaire manager of Greenlight Capital doesn’t exactly have a positive image of Tesla Inc (NASDAQ:TSLA) investors, viewing......(read more)
Tesla Inc (TSLA): Is It Doomed to the Same Fate As Radio Stocks?
Vilas Capital is probably no stranger to Tesla Inc (NASDAQ:TSLA) investors, as the fund has been an outspoken critic of Tesla in the past, calling it &#......(read more)
Cliffs Natural Resources Inc. (CLF): Why You Should Pay Attention to Burgeoning Insider Buying
Cliffs Natural Resources Inc. (NYSE:CLF) insiders have a history of buying up shares in clusters, the last cluster of which we saw in late-October/early......(read more)
Thermo Fisher Scientific Inc. (TMO): Why Billionaire Larry Robbins Loves This Stock
It’s been a tough run for Glenview Capital, the hedge fund run by billionaire Larry Robbins, which has endured two losing years in a row (an 18.......(read more)
Why The Corbus Pharmaceuticals Holdings Inc (CRBP) Cystic Fibrosis Results Are Very Positive
Last week, Corbus Pharmaceuticals Holdings Inc (NASDAQ:CRBP) announced data from a Phase II study of its lead development asset Anabasum. The data appeared......(read more)
The Threat And Risk Of Rising Interest Rates: Separating Fact From Fiction
Introduction The threat of rising interest rates is all the rage in financial circles today. However, the seminal question is: How real is the threat,......(read more)
Cannabis Space Continues To Shine As Latest IPO Therapix BioSciences (TRPX) Oversubscribed
The cannabis space has been one of the most closely watched, and the most active, sectors across the last twelve months. The Viridian Cannabis Stock Index......(read more)
FDA Sends Complete Response Letter To AstraZeneca PLC (ADR) (AZN) Following Rejection Of Hyperkalemia Drug
AstraZeneca PLC (ADR) (NYSE:AZN) has acknowledged the receipt of the Complete Response Letter (CRL) from the U.S. Food and Drug Administration for ZS......(read more)
Nektar Therapeutics (NKTR): Here’s What Just Happened
Nektar Therapeutics (NASDAQ:NKTR) is one of the week’s biggest winners in biotech so far, with the company soaring during the Monday session on the......(read more)
AstraZeneca PLC (ADR) (AZN) In Respiratory Drug Deal With Circassia Pharmaceuticals
In an effort to enhance collaboration with Circassia Pharmaceuticals, AstraZeneca PLC (ADR) (NYSE:AZN) has acquired an equity stake valued at $50 million......(read more)
Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Launches Minastrin Generic In The United States
Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) has unveiled the authorized generic version of Minastrin, an oral contraceptive that is combined......(read more)
Esperion Therapeutics Inc (ESPR): Get It While It’s Cheap
At the end of last week, Amgen, Inc. (NASDAQ:AMGN) announced some data from its large-scale trial of its cardiovascular risk asset Repatha. The drug first......(read more)
Two REITs Delivering High Growing Income For Retirees
As you know, I review the list of dividend increases every single week as part of my monitoring process. I usually focus my attention on the ones that......(read more)
Positive Results Reported For Ocular Therapeutix Inc (OCUL) Dextenza Following Phase III Study
Positive results for the Phase III study meant to test the experiences of patients using the eye insert known as Dextenza to relieve pain in a post-surgical......(read more)
Seres Therapeutics Inc (MCRB) Announces New “Poop Pill” Phase 2 Study
Plans to start a new Phase II study of SER-109, branded ECOSPOR III, have been announced by Seres Therapeutics Inc (NASDAQ:MCRB). The drug is meant to......(read more)
Target Corporation (TGT): An Attractively Valued Dividend Champion On Sale
Target Corporation (NYSE:TGT) operates general merchandise stores in the United States and Canada. Target is a dividend champion, which has paid dividends......(read more)
Biotech Movers On Friday: Neurotrope Inc (NTRP) And PTC Therapeutics, Inc. (PTCT)
Here’s a look at some of the week’s biggest movers in biotech, what’s moving them, and where we expect things to go early next week and beyond.......(read more)
